| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/19/2008 | US20080146571 potent deoxycytidine kinase inhibitors; O-linked pyrimidin-4-amine-based compounds |
| 06/19/2008 | US20080146565 JNK modulators |
| 06/19/2008 | US20080146542 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, Process for Preparing Them, Compositions Containing Them and Use Thereof |
| 06/19/2008 | US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 06/19/2008 | US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
| 06/19/2008 | US20080145698 Compounds For Organic Electronic Devices |
| 06/19/2008 | US20080142179 Sulfonated triazinylaminostilbene compounds; storage stability (does not need dispersants or other stabilizing additives); whitening of paper and other cellulosic substrates |
| 06/19/2008 | CA2672233A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 06/19/2008 | CA2672101A1 Compounds and compositions as kinase inhibitors |
| 06/19/2008 | CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 06/19/2008 | CA2671478A1 Non-nucleoside reverse transcriptase inhibitors |
| 06/19/2008 | CA2670726A1 6-oxo-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 06/18/2008 | EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 06/18/2008 | EP1932837A1 Bicyclo heterocyclic compound having antifungal action |
| 06/18/2008 | EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 06/18/2008 | EP1932831A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols |
| 06/18/2008 | EP1931655A2 A process for the preparation of sartan derivatives and intermediates useful in such process |
| 06/18/2008 | EP1931648A2 Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole |
| 06/18/2008 | EP1931647A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 06/18/2008 | EP1931646A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs |
| 06/18/2008 | EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 06/18/2008 | EP1931643A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
| 06/18/2008 | EP1931640A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 06/18/2008 | EP1931633A2 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
| 06/18/2008 | EP1931632A2 Useful indole compounds |
| 06/18/2008 | EP1931335A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 06/18/2008 | EP1853588B1 Chemical compounds |
| 06/18/2008 | EP1594861B1 Triazole compounds and the therapeutic use thereof |
| 06/18/2008 | EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/18/2008 | EP1485378B1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 06/18/2008 | CN101203511A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/18/2008 | CN101203491A Tetrahydrocarbazole derivatives used as androgen receptor modifier |
| 06/18/2008 | CN101203489A Oxindole derivatives |
| 06/18/2008 | CN101203134A Substituted arylpyrazoles as parasiticidal pharmaceutical product |
| 06/18/2008 | CN101200464A Method for preparing sartan drug candesartan treating hypertension |
| 06/17/2008 | US7388026 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 06/17/2008 | US7388024 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles |
| 06/17/2008 | US7388018 for controlling phytopathogenic harmful fungi; |
| 06/17/2008 | US7388013 Capped pyrazinoylguanidine sodium channel blockers |
| 06/17/2008 | US7388009 Heterocyclic drugs as enzyme inhibitors for Kinase enzymes or prodrugs |
| 06/17/2008 | CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders |
| 06/17/2008 | CA2451990C A new compound for the treatment of impotence |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/17/2008 | CA2331737C Agents for relieving side effects caused by use of an anti-tumour agent |
| 06/17/2008 | CA2249446C Irreversible inhibitors of tyrosine kinases |
| 06/12/2008 | WO2008070831A2 Bisbenzamidines and bisbenzamidoximes for the treatment of human african trypanosomiasis |
| 06/12/2008 | WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists |
| 06/12/2008 | WO2008070507A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | WO2008070447A2 Anti-viral compounds |
| 06/12/2008 | WO2008070336A2 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 06/12/2008 | WO2008069997A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | WO2008069313A1 Method for producing pyrrolidine compound |
| 06/12/2008 | WO2008068171A1 Substituted pyrimidines and their use as jnk modulators |
| 06/12/2008 | WO2008068157A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 06/12/2008 | WO2008067871A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 06/12/2008 | WO2008067756A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof |
| 06/12/2008 | WO2008067687A1 The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 06/12/2008 | WO2008051272A3 Somatostatin agonists |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139637 Reacting an alpha,beta-unsaturated compound and indole or indole derivative with a lewis acid catalyst; industrial scale synthesis of 1,1,3-tris(indol-3-yl)cyclohexane for example; treating cancer cells with the mutation of the p53 tumor suppressor gene |
| 06/12/2008 | US20080139628 Compositions For Treating Flushing And Lipid-Associated Disorders Comprising Niacin Receptor Partial Agonists |
| 06/12/2008 | US20080139619 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139568 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
| 06/12/2008 | US20080139560 Ion Channel Modulators |
| 06/12/2008 | US20080139555 1-[(4-{[4-(3-amino-6-methylphenyl)piperidyl]methyl}phenyl)sulfonyl]-4; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent |
| 06/12/2008 | US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease |
| 06/12/2008 | US20080139536 Benzodiazepines for Treating or Preventing Rsv Infection |
| 06/12/2008 | US20080139534 Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis |
| 06/12/2008 | US20080139533 Substituted 4-imidazoles |
| 06/12/2008 | US20080139532 Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents) |
| 06/12/2008 | US20080135803 Pyridyl derivatives with substituents of electrons push-pull effect; compounds are colorless and have high thermal and photo stability as well as high compatibility in liquid crystal host; can reduce threshold voltage of cholesteric reflective displays, saving power and extending lifetime of driver ICs |
| 06/12/2008 | CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | CA2670375A1 Substituted pyrimidines and their use as jnk modulators |
| 06/12/2008 | CA2669590A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1928872A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
| 06/11/2008 | EP1928862A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 06/11/2008 | EP1928861A1 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 06/11/2008 | EP1928860A1 Novel 2,3-dihydroindole compounds |
| 06/11/2008 | EP1928859A1 Pyrazole derivates as cannabinoid receptor modulators |
| 06/11/2008 | EP1928858A1 Solid salt forms of a pyrrole substituted 2-indolinone |
| 06/11/2008 | EP1928857A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 06/11/2008 | EP1928846A2 Triazole compounds that modulate hsp90 activity |
| 06/11/2008 | EP1928843A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 06/11/2008 | EP1928842A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 06/11/2008 | EP1928840A1 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta-hydroxysteroid dehydrogenase |
| 06/11/2008 | EP1928455A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/11/2008 | EP1509517B1 Novel synthesis of irbesartan |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | EP1463501B1 Cis-imidazolines as mdm2 inhibitors |
| 06/11/2008 | EP1313713B1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | CN101198607A Phenylacetamides suitable as protein kinase inhibitors |
| 06/11/2008 | CN101198596A 2-amino-quinaz0lin-5-ones as HSP90 inhibitors useful in treating proliferation diseases |